Sharing our perspective

Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward.


  • UPDATE: Florida takes regulatory action on compounds

    by
    • Optum Workers' Comp
    | Jun 30, 2017
    Tag Icon
    Workers' Compensation
    In response to a recent workcompcentral.com article regarding the pre-authorization of compounds over $1000 in Florida, we take this opportunity to re-release our blog post of May 11, 2017. Our original blog noted that the change in the pre-authorization applies to all compounded medications regardless of the billed amount. Pharmacies may submit compounded medications for pre-authorization and the claims administrator now has 10 days to respond to that request.


  • First-time generic approved for Truvada®

    by
    • Optum Workers' Comp
    | Jun 29, 2017
    Tag Icon
    Generics, FDA
    The U.S. Food and Drug Administration (FDA) recently approved Teva’s AB-rated generic for Gilead’s Truvada® (emtricitabine/tenofovir disoproxil fumarate) 200 mg/300 mg oral tablet. This is the first time a generic has been approved for this medication. Truvada is a combination antiretroviral medication indicated for use in combination with other antiretroviral medications for the treatment of human immunodeficiency virus type-1 (HIV-1) infection in adults and pediatric patients weighing at least 17 kg (approximately 37.5 pounds), and in combination with safer sex practices for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in adults at high risk.


  • Teva introduces generic Skelaxin®

    by
    • Optum Workers' Comp
    | Jun 22, 2017
    Tag Icon
    Generics
    Teva Pharmaceuticals announced it will be manufacturing a generic version of Skelaxin® (metaxalone) tablets. Skelaxin is a skeletal muscle relaxant used to relieve discomfort associated with acute, painful musculoskeletal conditions as an adjunctive therapy. Metaxalone is currently available in 400 mg and 800 mg tablets; however, Teva is only advertising the launch of 800 mg tablets. This new generic adds to a list of other previously released generic metaxalone tablets.


  • Update to Voluntary recall of Eliquis® (apixaban) 5 mg tablets

    by
    • Optum Workers' Comp
    | Jun 22, 2017
    Tag Icon
    Medication Recall, FDA
    UPDATE: On June 10, one lot of Eliquis was recalled and designated as a consumer-level recall. On June 17, this recall was changed to a retail/dispensing level only recall. The recall is currently underway at the pharmacy level. As a reminder, patients should not stop taking Eliquis without consulting with their doctor. For more information on this update, click here.






Subscribe

Stay informed by signing up to receive newsletters, alerts, insights and videos.
You can customize your content preferences after you subscribe.